German pharmaceuticals giant Bayer has completed its takeover of American GMO company Monsanto. Shareholders have reportedly accepted $128 a share, making the deal worth $66 billion, including debt. The deal is the largest corporate takeover in almost two decades for[…]↓ Read the rest of this entry…